enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Lipodystrophy

    Lipodystrophy syndromes are a group of genetic or acquired disorders in which the body is unable to produce and maintain healthy fat tissue. [ 1 ] [ 2 ] The medical condition is characterized by abnormal or degenerative conditions of the body's adipose tissue .

  3. Localized lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Localized_lipodystrophy

    Localized lipodystrophy is a skin condition characterized by the loss of subcutaneous fat localized to sites of insulin injection. [1]: ... By using this site, ...

  4. Lipohypertrophy - Wikipedia

    en.wikipedia.org/wiki/Lipohypertrophy

    Lipohypertrophy usually will gradually disappear over months if injections in the area are avoided. It is a common misconception that the lump is largely scar tissue, as injection site hypertrophy is much rarer and milder with injections of other hormones and medications which lack the specific ability of insulin to stimulate adipose hypertrophy.

  5. Lipoatrophy - Wikipedia

    en.wikipedia.org/wiki/Lipoatrophy

    Lipoatrophy occurs in HIV-associated lipodystrophy, one cause of which is an adverse drug reaction that is associated with some antiretroviral medications. [2] A more general term for an abnormal or degenerative condition of the entire body's adipose tissue is lipodystrophy.

  6. Insulin aspart - Wikipedia

    en.wikipedia.org/wiki/Insulin_aspart

    The side effects that are commonly associated with insulin therapy include: allergic reactions, injection site irritation, rashes, and hypoglycemia. [23] The most common side effect is hypoglycemia. Long-term use of insulin, including insulin aspart, can cause lipodystrophy at the site of repeated injections or infusion. To reduce the risk of ...

  7. Tesamorelin - Wikipedia

    en.wikipedia.org/wiki/Tesamorelin

    Tesamorelin (trade name Egrifta SV) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010. It is produced and developed by Theratechnologies, Inc. of Canada.

  8. Injection site reaction - Wikipedia

    en.wikipedia.org/wiki/Injection_site_reaction

    Injection site reactions (ISRs) are reactions that occur at the site of injection of a drug. They may be mild or severe and may or may not require medical intervention. Some reactions may appear immediately after injection, and some may be delayed. [1] Such reactions can occur with subcutaneous, intramuscular, or intravenous administration.

  9. Lipoatrophic diabetes - Wikipedia

    en.wikipedia.org/wiki/Lipoatrophic_diabetes

    English. Read; Edit; View history ... Lipoatrophic diabetes is a type of diabetes mellitus presenting with severe lipodystrophy in addition to the ... By using this ...